Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period

BACKGROUND: The effect of preadmission metformin usage (PMU) on the mortality of coronavirus disease-2019 (COVID-19) patients with diabetes is conflicting. Most studies have focused on in-hospital mortality; however, mortality after discharge also increases in COVID-19 patients. AIMS: Examining the...

Descripción completa

Detalles Bibliográficos
Autores principales: Saygili, Emre Sedar, Karakiliç, Ersen, Mert, Erdal, Şener, Alper, Mirci, Arzu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553499/
https://www.ncbi.nlm.nih.gov/pubmed/34713419
http://dx.doi.org/10.1007/s11845-021-02823-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553499/
https://www.ncbi.nlm.nih.gov/pubmed/34713419
http://dx.doi.org/10.1007/s11845-021-02823-9

Ejemplares similares